CANNA RIVER RELEASES ‘ULTRA’ INTO PERMANENT COLLECTION AS CONSUMER DEMAND SIGNALS FOR HIGH POTENCY MINOR CANNABINOID PRODUCTS


Ryan Allway

September 20th, 2022

News, Top News


CANNA RIVER RELEASES ‘ULTRA’ INTO PERMANENT COLLECTION AS CONSUMER DEMAND SIGNALS FOR HIGH POTENCY MINOR CANNABINOID PRODUCTS
The $100 or less premium cannabinoid brand introduces 20,000mg Ultra tinctures in Classic, Calm, Sleep and Wellness as a response to custom orders for products that support ailment relief
September 20, 2022 (LOS ANGELES) – Canna River, the premium quality cannabinoid brand offering its entire selection for $100 or less, introduces new minor cannabinoids blends alongside the launch of Ultra, a high potency line of tinctures requested by the company’s repeat customers.
Ultra is presented in 20,000mg bottles of premium quality CBD, CBN, and CBG ratios and geared toward potentially relieving aches, pains, aiding sleep, and more.
“We noticed our customers continually requesting higher potency product,” said Canna River founder Grant Boatman. “We decided to release the Ultra collection so that we could provide our growing community with the strongest tinctures, at the fairest price. Traditional CBD products have always seemed too expensive for those that need it most. The Ultra Tincture breaks out of that box, showing that premium hemp wellness no longer requires a premium price.”

Alongside Ultra, Canna River also introduced minor cannabinoids blends with CBD, CBN and CBG. An overview of Canna River’s latest collection is as follows:

  • Ultra Classic: 20,000mg Broad Spectrum CBD ($100)
  • Classic Full Spectrum: 1500mg, 3000mg, 6000mg and 12000mg Full Spectrum CBD ($20-$80)
  • Classic Broad Spectrum: 1500mg, 3000mg, 6000mg and 12000mg Broad Spectrum CBD ($20-$80)
  • Ultra Calm: 6:1:1 15,000mg Broad Spectrum CBD / 2500mg CBN / 2500mg CBG ($100)
  • Calm: 4:1:1 5,000mg Broad Spectrum CBD / 1250mg CBN / 1250mg CBG ($65)
  • Ultra Sleep: 3:1 15,000mg Broad Spectrum CBD / 5000mg CBN ($100)
  • Sleep: 2:1 5,000mg Broad Spectrum CBD / 2500mg CBN ($65)
  • Ultra Wellness: 3:1 15,000mg Broad Spectrum CBD / 5000 CBG ($100)
  • Wellness: 2:1 5,000mg Broad Spectrum CBD / 2500 CBG ($65)

All tinctures are available in Lemon Raspberry, Mango Peach, and Sweet Mint flavors and the Classic is also available in Natural.  Tinctures contain premium hemp-derived cannabinoids from USA grown hemp and are Farm Bill compliant, lab tested, vegan, cruelty free, alcohol free, sugar free and non-GMO. View Certificate of Analysis for all Canna River tinctures here.

In addition to the tinctures, Canna River’s current product catalog includes Delta 8 Tinctures, Delta 8 Gummies, Delta 8 + 10 Highlighter Disposables, HHC Highlighters, and CBD Gummies all ranging in flavors and strains. The CBD Gummies, like the tinctures, tackle specific needs by blending minor cannabinoids with vitamins and natural ingredients. The gummies – Energy, Immunity, Recovery, Multi-Vitamin, Pain and Stress – contain 25mg of choice cannabinoid per piece and have become a best seller alongside the HHC Highlighters that launched in June 2022.
Canna River can be found at dispensaries nationwide as well as direct-to-consumer at  cannariver.com.  Affiliate link available for media and influencers at this link with 25% commission.  Additionally, they offer free shipping on all orders and a 30% off code to the following customers through Verify Pass: Military (Active Duty, Veterans and Dependents), First Responders (Police, Fire and EMT), Medical Personnel (Doctors, Nurses and Medical Staff), Teachers, Seniors (Age 55+), Commercial Drivers, Non-Profits (Owners and Employees), Union Members, and Disadvantaged Communities (Disabled, Low-income, Unemployed).
To learn more visit cannariver.com or follow on Instagram at @cannariver.
For hi-res images of Ultra, please visit this link.
About Canna River
Modern life can take a toll on our minds and bodies. Canna River offers products to enrich a range of lifestyles and offers ultra high potency, premium cannabinoids for $100 or less. Launched in 2019, the brand set out to make a collection more accessible across all operations as a supplier, manufacturer and retailer. Today, Canna River offers tinctures, edibles, vapes and topicals across a range of products that include CBD, CBG, CBN, Delta 8 + 10 and HHC with strengths ranging from 1500mg to 20000mg. The brand proudly offers more and costs less. If society can get the support they need without breaking the bank, Canna River has succeeded.  View Certificate of Analysis for all Canna River products  here. Find Canna River products at select retailers and online at cannariver.com.
Media Contact
mae lasso

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading